rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-9-22
|
pubmed:abstractText |
PRIMA-1 has emerged as a small molecule that restores the wild type function to mutant p53. To identify molecular targets that are involved in PRIMA-1-induced apoptosis, we used a proteomics approach with two-dimensional gel electrophoresis coupled with liquid chromatography-tandem mass spectrometry for protein identification. By comparing the proteome of the PRIMA-1-treated MDA-231 breast carcinoma cells with that of MCF-7 cells, we have identified seven proteins that upregulated only in MDA-231 cells as a result of PRIMA-1-induced apoptosis. The identified proteins are involved in anaerobic glycolysis and in mitochondrial intrinsic apoptosis. Treatment of MDA-231 cells with PRIMA-1 resulted in the release of mitochondrial cytochrome c as well as the activation of caspase-3, which are essential for the execution of apoptosis. We present evidence to suggest that PRIMA-1-induced apoptosis in breast cancer cells with mutated p53 function involved the expression of proteins required for the activation of mitochondrial intrinsic pathway that is glycolysis-relevant.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
349
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1117-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16970918-Aza Compounds,
pubmed-meshheading:16970918-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:16970918-Breast Neoplasms,
pubmed-meshheading:16970918-Caspase 3,
pubmed-meshheading:16970918-Caspases,
pubmed-meshheading:16970918-Cell Line, Tumor,
pubmed-meshheading:16970918-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:16970918-Enzyme Activation,
pubmed-meshheading:16970918-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16970918-Humans,
pubmed-meshheading:16970918-Mass Spectrometry,
pubmed-meshheading:16970918-Microscopy, Electron, Transmission,
pubmed-meshheading:16970918-Proteomics,
pubmed-meshheading:16970918-Tumor Suppressor Protein p53
|
pubmed:year |
2006
|
pubmed:articleTitle |
Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, Washington State University, 259 Wegner Hall, Pullman, WA 99164-6534, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|